Research Article: Race and Ethnic and Sex Differences in Rhythm Control Treatment of Incident Atrial Fibrillation
Abstract:
Atrial fibrillation (AF) is the most common abnormal heart rhythm disorder in the United States (US). Approximately million individuals have AF in the US, with the prevalence of AF expected to increase to million by .– Antiarrhythmic drug (AAD) therapy and catheter ablation are rhythm control strategies implemented to prevent recurrent AF and maintain sinus rhythm. Results from a multi-center trial, the Early Treatment of Atrial Fibrillation for Stroke Prevention Trial (EAST-AFNET ), demonstrated benefits of early rhythm control including improved cardiovascular outcomes in AF patients. Guidelines from the American College of Cardiology, the American Heart Association, and the Heart Rhythm Society recommend catheter ablation as the first-line therapy for patients with recurrent symptomatic paroxysmal and persistent AF prior to trial of Class I or III AAD.
Introduction:
Atrial fibrillation (AF) is the most common abnormal heart rhythm disorder in the United States (US). Approximately million individuals have AF in the US, with the prevalence of AF expected to increase to million by . – Antiarrhythmic drug (AAD) therapy and catheter ablation are rhythm control strategies implemented to prevent recurrent AF and maintain sinus rhythm. Results from a multi-center trial, the Early Treatment of Atrial Fibrillation for Stroke Prevention Trial (EAST-AFNET ), demonstrated benefits of…
Read more